Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Tyler Hepworth

Physician Assistant, Medical Pocatello, ID Physician Assistant

NPI 1447541487 CMS profile 11233212

777 Hospital Way, Pocatello, ID 83201

Open in the dashboard

General payments

$7,358

469 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tyler Hepworth of Pocatello, ID is reported in the CMS Open Payments database as having received $7,358 across 469 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,531 90
2024 General $1,478 93
2023 General $1,330 80
2022 General $1,769 115
2021 General $1,250 91

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tyler Hepworth
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Tyler Hepworth were reported at $1,531. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Tyler Hepworth Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $1,250 $156 $41–$563 $132
2022 $1,769 $185 $55–$649 $149
2023 $1,330 $199 $58–$717 $160
2024 $1,478 $206 $62–$740 $164
2025 $1,531 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $2,378 130 payments
  2. Boston Scientific Corporation $1,903 151 payments
  3. Abbott Laboratories $720 42 payments
  4. Medtronic, Inc. $602 33 payments
  5. Nalu Medical, Inc. $576 33 payments
  6. Lilly USA, LLC $205 20 payments
  7. Salix Pharmaceuticals, a division of Bausch Health US, LLC $148 8 payments
  8. Nevro Corp. $115 3 payments
  9. Globus Medical, Inc. $112 5 payments
  10. Stimwave Technologies Incorporated $107 11 payments
  11. Other $493 33 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,358 469 payments
Products named General payments · program years 2021–2025
  1. UBRELVY $1,828 96 payments
  2. QULIPTA $1,465 86 payments
  3. Nalu Neurostimulation System $576 33 payments
  4. General - Pain Management $402 34 payments
  5. WaveWriter Alpha Prime 16 $341 21 payments
  6. PROCLAIM $341 17 payments
  7. SYNCHROMEDII $224 8 payments
  8. EMGALITY $205 20 payments
  9. REYVOW $205 20 payments
  10. Proclaim IPG $201 15 payments
  11. Other $2,391 167 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 51 drugs

Part D claims

6,076

Median for Physician Assistant: 241

Drug cost

$408,759

Median for Physician Assistant: $4,110

Branded share of claims

37.4%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Buprenorphine Generic 217 $79,961
Belbuca Buprenorphine Hcl Brand 58 $47,575
Ubrelvy Ubrogepant Brand 24 $37,406
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 999 $28,390
Oxycodone Hcl Generic 763 $25,937
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 650 $22,711
Qulipta Atogepant Brand 18 $20,012
Pregabalin Generic 323 $19,341
Aimovig Autoinjector Erenumab-Aooe Brand 25 $18,022
Butrans Buprenorphine Brand 27 $13,119

The 10 drugs with the highest cost, of 51 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$83,270

Of which drugs: $13,105

Medicare patients

150

Average age 66

Services billed

4,279

89 women, 61 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 69%
Depression 43%
Diabetes 33%
Ischemic heart disease 23%
Chronic kidney disease 23%
COPD 21%
Heart failure 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 16 762 $79

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 8 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
UBRELVY
  • AbbVie, Inc. $277
$277 24 —
QULIPTA
  • AbbVie, Inc. $277
$277 18 —
RELISTOR
  • Salix Pharmaceuticals, a division of Bausch Health US, LLC $86
$86 — —
Qutenza
  • Averitas Pharma Inc. $20
$20 — —
VRAYLAR
  • AbbVie, Inc. $19
$19 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 8 in the dashboard with a free account

Records

469 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record